Acylated uridine and cytidine for elevating tissue uridine and cytidine
US5583117A · kind A · utility
24Cited by
8References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 1993 |
| Grant date | Dec 10, 1996 |
| Priority date | — |
| Expiry date | Oct 25, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
General methods for delivering exogenous cytidine or uridine to the tissue of an animal comprising the administration of acylated cytidine or acylated uridine, respectively, are disclosed. Methods of treating myocardial infarction and cardiac insufficiency comprising the administration of acylated cytidine or acylated uridine, are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.